15.01.2015 Views

Télécharger le texte intégral

Télécharger le texte intégral

Télécharger le texte intégral

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

saquinavir 1.6 (0.7-3.7) 0.30<br />

fosamprenavir* 0.4 (0.1-1.1) 0.06<br />

lopinavir/r 1.2 (0.7-2.3) 0.51<br />

NRTI 1.6 (0.7-3.2) 0.23<br />

abacavir 1.1 (0.6-1.8) 0.86<br />

tenofovir 1.1 (0.7-1.8) 0.70<br />

NNRTI 1.2 (0.7-2.2) 0.53<br />

efavirenz 1.1 (0.5-2.3) 0.86<br />

nevirapine 1.4 (0.5-3.3) 0.51<br />

* Variab<strong>le</strong>s included in multivariate analyses; PI: protease inhibitor; NRTI: nuc<strong>le</strong>oside reverse<br />

transcriptase inhibitor; NNRTI: non-nuc<strong>le</strong>oside reverse transcriptase inhibitor ;γGT: gamma–<br />

glutamyl-transpeptidase; ALT: alanine aminotransferase; AST: aspartate aminotransferase;<br />

ULN: upper limit of normal<br />

Notes : AST was not included in multivariate analyses as it was highly correlated with ALT<br />

(r=0.83, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!